Cravath’s London Office Moves to 100 Cheapside
Venture Capital & Growth Equity
Cravath advises innovative and forward‑thinking technology companies, venture capital investors and other advisors and capital sources on a wide range of transactions pivotal for growth. Our corporate clients include venture capital- and private equity‑backed businesses across software, hardware, fintech, blockchain and digital assets, artificial intelligence (AI), biotechnology, medical devices, clean tech and renewables and other developing areas. Our investor representations include venture capital and growth equity firms, corporate venture capital arms and other institutional partners. This interdisciplinary practice focuses on key venture investment rounds and other financing arrangements, including preferred equity, SAFEs, venture debt and traditional and synthetic royalty arrangements; joint ventures, collaboration agreements and licensing arrangements; and employee tender offers and other pre‑IPO liquidity events. Our attorneys also regularly represent clients in connection with IPOs, direct listings, de‑SPACs, mergers and acquisitions and other late‑stage transactional matters. We are adept at navigating the unique accommodations and considerations for international companies interested in tapping into the U.S. markets, whether through a private capital raise, IPO or other listing alternative.
Our dedicated team partners closely with clients, drawing upon the Firm’s rich history of collaboration with founders and innovators to provide thoughtful, strategic and pragmatic counsel. We understand that rapid growth and revolutionary new technologies lead to complex and unexpected shifts in the legal and regulatory landscape. Our targeted advice ensures that our clients remain at the forefront, prepared to navigate and capitalize on transformative developments. Clients further benefit from our deep specialty expertise in areas such as cybersecurity and data privacy, intellectual property, tax and executive compensation and benefits. In addition, international companies and investment firms frequently turn to Cravath for our extensive transactional and regulatory experience in cross-border matters, including those pertaining to CFIUS and national security.
Illustrative recent transactions include:
- Circle’s Regulatory Clarity Amidst IPO Process;
- Galaxy Digital Inc.’s First SEC‑Registered Underwritten Offering of Class A Common Stock;
- Wiz’s $32 Billion Acquisition by Google;
- The separation by Medal, the largest platform for sharing short-form gaming content, of its AI assistant platform, Highlight;
- Brevan Howard Digital’s investments in digital asset and blockchain companies including Super Turbo, Time.fun and Starlight Tech;
- Bristol Myers Squibb’s investments in biotechnology companies including Asher Bio, COUR Pharmaceuticals and Q32 Bio;
- Tata Technologies Limited’s IPO;
- Monogram Health Holdings’ Series C Financing Round;
- Swvl’s SPAC Combination with Queen’s Gambit Growth Capital;
- Alliance Animal Health’s Significant Growth Investment from L Catterton;
- Vaxxinity, Inc.’s Initial Public Offering;
- IsoPlexis Corporation’s Initial Public Offering;
- SPANX’s Sale of a Majority Stake to Blackstone;
- On Holding’s Initial Public Offering of Class A Ordinary Shares;
- Robinhood’s IPO;
- Cherry AG’s Initial Public Offering of Ordinary Bearer Shares;
- Convey Holding Parent, Inc.’s Initial Public Offering of Common Stock;
- Aras’s Significant Growth Investment by GI Partners;
- Cazoo’s $8.1 Billion Business Combination with SPAC AJAX I; and
- Robinhood’s $3.4 Billion Capital Raise.
Our dedicated team partners closely with clients, drawing upon the Firm’s rich history of collaboration with founders and innovators to provide thoughtful, strategic and pragmatic counsel. We understand that rapid growth and revolutionary new technologies lead to complex and unexpected shifts in the legal and regulatory landscape. Our targeted advice ensures that our clients remain at the forefront, prepared to navigate and capitalize on transformative developments. Clients further benefit from our deep specialty expertise in areas such as cybersecurity and data privacy, intellectual property, tax and executive compensation and benefits. In addition, international companies and investment firms frequently turn to Cravath for our extensive transactional and regulatory experience in cross-border matters, including those pertaining to CFIUS and national security.
Illustrative recent transactions include:
- Circle’s Regulatory Clarity Amidst IPO Process;
- Galaxy Digital Inc.’s First SEC‑Registered Underwritten Offering of Class A Common Stock;
- Wiz’s $32 Billion Acquisition by Google;
- The separation by Medal, the largest platform for sharing short-form gaming content, of its AI assistant platform, Highlight;
- Brevan Howard Digital’s investments in digital asset and blockchain companies including Super Turbo, Time.fun and Starlight Tech;
- Bristol Myers Squibb’s investments in biotechnology companies including Asher Bio, COUR Pharmaceuticals and Q32 Bio;
- Tata Technologies Limited’s IPO;
- Monogram Health Holdings’ Series C Financing Round;
- Swvl’s SPAC Combination with Queen’s Gambit Growth Capital;
- Alliance Animal Health’s Significant Growth Investment from L Catterton;
- Vaxxinity, Inc.’s Initial Public Offering;
- IsoPlexis Corporation’s Initial Public Offering;
- SPANX’s Sale of a Majority Stake to Blackstone;
- On Holding’s Initial Public Offering of Class A Ordinary Shares;
- Robinhood’s IPO;
- Cherry AG’s Initial Public Offering of Ordinary Bearer Shares;
- Convey Holding Parent, Inc.’s Initial Public Offering of Common Stock;
- Aras’s Significant Growth Investment by GI Partners;
- Cazoo’s $8.1 Billion Business Combination with SPAC AJAX I; and
- Robinhood’s $3.4 Billion Capital Raise.
Activities
October 14, 2025
Kathryn-Ann Stamm Speaks at NYU SBLA’s “Legal Side of Startups” Panel
On October 9, 2025, Cravath of counsel Kathryn‑Ann Stamm participated in a panel entitled “Legal Side of Startups,” hosted by the NYU Stern Business and Law Association (“SBLA”). SBLA is dedicated to exploring the intersection between business and law by sharing practical insights from professionals involved in corporate law, strategy and entrepreneurship. During the panel, Kathryn‑Ann spoke about the interplay between venture capital and intellectual property (“IP”) law, emphasizing how early‑stage IP strategies underpin valuation, diligence readiness and long‑term success. She also explored scaling challenges as startups mature and discussed how emerging technologies, including AI, are reshaping diligence, licensing, data use and product development.
Activities
October 07, 2025
Elad Roisman Speaks at Fordham Law’s 2025 Blockchain Regulatory Symposium
On October 6, 2025, Cravath partner Elad Roisman participated in the 2025 Blockchain Regulatory Symposium, hosted by Fordham Law School in New York City. The symposium provided a platform for discussions on a range of topics, including the tension between innovation and regulation in the U.S. and globally. Elad spoke on a panel entitled “Wall Street Meets Crypto... on Wall Street,” which brought together leading corporate, capital markets and M&A practitioners to discuss key considerations as crypto companies begin transitioning from private market launchpads to public markets and what comes next.
Activities
September 29, 2025
Nico Lupea Speaks at 8th Annual IBA European Start‑up Conference
On September 25, 2025, European counsel Nicoleta D. Lupea participated in the 8th Annual IBA European Start‑up Conference in Cascais, Portugal. Nico spoke on a panel entitled “Navigating Ethics for Startup Lawyers.” The panel highlighted the unique ethical challenges faced by lawyers advising fast‑growing companies and investors, including managing conflicts of interest in founder–investor dynamics, preserving confidentiality, ensuring competence and maintaining transparency around fees. The panel also emphasized the benefits of strong ethical standards in safeguarding clients’ trust and supporting sustainable growth and the integrity of the profession in the startup and growth equity ecosystem.
Activities
September 17, 2025
Scott Bennett Co‑Leads Roundtable at The L Suite’s 2025 General Counsel IPO Conference
On September 17, 2025, Cravath partner D. Scott Bennett participated in The L Suite’s 2025 General Counsel IPO Conference, which was held from September 16‑17 in San Francisco. The conference hosted general counsels and chief legal officers at early, growth and late‑stage private companies to discuss strategic insights and legal guidance for navigating the evolving IPO landscape, including market timing, raise sizing, managing late-stage investors, dual‑track and SPAC considerations and sector-specific momentum in areas like technology and AI. Scott co‑led a roundtable discussion entitled “Leading Through the Unknown: The GC’s Role in IPO‑Adjacent Crisis Management,” which explored how general counsels can proactively build crisis response into IPO planning, support the CEO and leadership team under pressure, maintain investor confidence and manage legal exposure when plans shift unexpectedly.
Publications
August 11, 2025
Cravath Venture Capital & Growth Equity Insights: 2025 Mid‑Year Market Update
On August 11, 2025, Cravath published the latest edition of its Venture Capital & Growth Equity Insights newsletter, which has been redesigned to provide greater insight into global venture capital and related activity during the first half of 2025 and outlook for the rest of the year. Key takeaways from this edition include:
Activities
October 14, 2025
Kathryn-Ann Stamm Speaks at NYU SBLA’s “Legal Side of Startups” Panel
On October 9, 2025, Cravath of counsel Kathryn‑Ann Stamm participated in a panel entitled “Legal Side of Startups,” hosted by the NYU Stern Business and Law Association (“SBLA”). SBLA is dedicated to exploring the intersection between business and law by sharing practical insights from professionals involved in corporate law, strategy and entrepreneurship. During the panel, Kathryn‑Ann spoke about the interplay between venture capital and intellectual property (“IP”) law, emphasizing how early‑stage IP strategies underpin valuation, diligence readiness and long‑term success. She also explored scaling challenges as startups mature and discussed how emerging technologies, including AI, are reshaping diligence, licensing, data use and product development.
Activities
October 07, 2025
Elad Roisman Speaks at Fordham Law’s 2025 Blockchain Regulatory Symposium
On October 6, 2025, Cravath partner Elad Roisman participated in the 2025 Blockchain Regulatory Symposium, hosted by Fordham Law School in New York City. The symposium provided a platform for discussions on a range of topics, including the tension between innovation and regulation in the U.S. and globally. Elad spoke on a panel entitled “Wall Street Meets Crypto... on Wall Street,” which brought together leading corporate, capital markets and M&A practitioners to discuss key considerations as crypto companies begin transitioning from private market launchpads to public markets and what comes next.
Activities
September 29, 2025
Nico Lupea Speaks at 8th Annual IBA European Start‑up Conference
On September 25, 2025, European counsel Nicoleta D. Lupea participated in the 8th Annual IBA European Start‑up Conference in Cascais, Portugal. Nico spoke on a panel entitled “Navigating Ethics for Startup Lawyers.” The panel highlighted the unique ethical challenges faced by lawyers advising fast‑growing companies and investors, including managing conflicts of interest in founder–investor dynamics, preserving confidentiality, ensuring competence and maintaining transparency around fees. The panel also emphasized the benefits of strong ethical standards in safeguarding clients’ trust and supporting sustainable growth and the integrity of the profession in the startup and growth equity ecosystem.
Activities
September 17, 2025
Scott Bennett Co‑Leads Roundtable at The L Suite’s 2025 General Counsel IPO Conference
On September 17, 2025, Cravath partner D. Scott Bennett participated in The L Suite’s 2025 General Counsel IPO Conference, which was held from September 16‑17 in San Francisco. The conference hosted general counsels and chief legal officers at early, growth and late‑stage private companies to discuss strategic insights and legal guidance for navigating the evolving IPO landscape, including market timing, raise sizing, managing late-stage investors, dual‑track and SPAC considerations and sector-specific momentum in areas like technology and AI. Scott co‑led a roundtable discussion entitled “Leading Through the Unknown: The GC’s Role in IPO‑Adjacent Crisis Management,” which explored how general counsels can proactively build crisis response into IPO planning, support the CEO and leadership team under pressure, maintain investor confidence and manage legal exposure when plans shift unexpectedly.
Publications
August 11, 2025
Cravath Venture Capital & Growth Equity Insights: 2025 Mid‑Year Market Update
On August 11, 2025, Cravath published the latest edition of its Venture Capital & Growth Equity Insights newsletter, which has been redesigned to provide greater insight into global venture capital and related activity during the first half of 2025 and outlook for the rest of the year. Key takeaways from this edition include:
Cravath Bicentennial
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.